C06848-2026

SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)
Sep 15, 2026
2. SEC Identification Number
CS200251064
3. BIR Tax Identification No.
219075614000
4. Exact name of issuer as specified in its charter
MEDILINES DISTRIBUTORS INCORPORATED
5. Province, country or other jurisdiction of incorporation
METRO MANILA, PHILIPPINES
6. Industry Classification Code(SEC Use Only)
7. Address of principal office
3rd Floor Vistamall Hub, C.V Starr Avenue Pamplona Dos, Las Piñas City Postal Code 1740
8. Issuer's telephone number, including area code
(632) 8519-1373
9. Former name or former address, if changed since last report
No change in address since its last report to this Honorable Commission
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares 2,746,575,800
11. Indicate the item numbers reported herein
Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Medilines Distributors IncorporatedMEDIC

PSE Disclosure Form 13-1 - Change in Shareholdings of
Directors and Principal Officers References: SRC Rule 23 (SEC Form 23-B) and
Section 13 of the Revised Disclosure Rules

Subject of the Disclosure

Changes in Shareholdings of the Chairman of the Board

Background/Description of the Disclosure

Reporting the Changes in Shareholdings of the Chairman of the Board as of 15 September 2026

Name of Person Virgilio B. Villar
Position/Designation Chairman of the Board
For Equity Securities
Type of Security / Stock Symbol Date of Transaction Securities Acquired (A) or Disposed (D) Ownership Form Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Number of Shares (A) or (D) Price per Share
Common Shares Sep 4, 2026 80,000 A 0.2200 I Held indirectly through Philstocks
Common Shares Sep 8, 2026 100,000 A 0.2230 I Held indirectly through Philstocks
Common Shares Sep 8, 2026 50,000 A 0.2220 I Held indirectly through Philstocks
Common Shares Sep 9, 2026 50,000 A 0.2310 I Held indirectly through Philstocks
Common Shares Sep 9, 2026 30,000 A 0.2300 I Held indirectly through Philstocks
Common Shares Sep 10, 2026 380,000 A 0.2210 I Held indirectly through Philstocks
Common Shares Sep 10, 2026 100,000 A 0.2310 I Held indirectly through Philstocks
Common Shares Sep 10, 2026 100,000 A 0.2200 I Held indirectly through Philstocks
Common Shares Sep 10, 2026 50,000 A 0.2100 I Held indirectly through Philstocks
Common Shares Sep 11, 2026 260,000 A 0.2200 I Held indirectly through Philstocks
Common Shares Sep 14, 2026 80,000 A 0.2200 I Held indirectly through Philstocks
Number of Shares Owned after the Transaction
Direct 1,005,002,800
Indirect 118,866,000
Filed on behalf by:
Name Myra De Asis
Designation Chief Financial Officer